284 related articles for article (PubMed ID: 30117140)
21. Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials.
Mei X; Wang L; Zhang R; Zhong S
Photodiagnosis Photodyn Ther; 2019 Mar; 25():23-28. PubMed ID: 30412779
[TBL] [Abstract][Full Text] [Related]
22. Comparison of clinical and histologic findings in daylight photodynamic therapy for skin field cancerization: A randomized controlled four-arm study on physical methods-assisted delivery of methyl aminolevulinate.
Bento CO; Pantaleão L; de Souza MB; Vilar EAG; Luiz RR; Filho PJS; Gismondi RAOC; Issa MCA
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102404. PubMed ID: 34133958
[TBL] [Abstract][Full Text] [Related]
23. Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis.
Holzer G; Pinkowicz A; Radakovic S; Schmidt JB; Tanew A
Br J Dermatol; 2017 May; 176(5):1155-1161. PubMed ID: 28012181
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial.
Choi SH; Kim KH; Song KH
Br J Dermatol; 2015 Jul; 173(1):184-91. PubMed ID: 25400009
[TBL] [Abstract][Full Text] [Related]
25. Effect of Expedited Microneedle-Assisted Photodynamic Therapy for Field Treatment of Actinic Keratoses: A Randomized Clinical Trial.
Petukhova TA; Hassoun LA; Foolad N; Barath M; Sivamani RK
JAMA Dermatol; 2017 Jul; 153(7):637-643. PubMed ID: 28514458
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight protocol) compared with the conventional protocol involving irradiation with the Aktilite CL 128 lamp.
Vicentini C; Vignion-Dewalle AS; Thecua E; Lecomte F; Maire C; Deleporte P; Béhal H; Kerob D; Duhamel A; Mordon S; Mortier L
Br J Dermatol; 2019 Apr; 180(4):765-773. PubMed ID: 30367470
[TBL] [Abstract][Full Text] [Related]
28. Randomized clinical trial testing the efficacy and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of skin field cancerization: study protocol.
Miola AC; Ferreira ER; Abbade LPF; Schmitt JV; Miot HA
BMC Cancer; 2018 Mar; 18(1):340. PubMed ID: 29587662
[TBL] [Abstract][Full Text] [Related]
29. Ablative Fractional Laser Enhances Artificial or Natural Daylight Photodynamic Therapy of Actinic Field Cancerization: A Randomized and Investigator-initiated Half-side Comparative Study.
Lindholm V; Salmivuori M; Hahtola S; Kerttu Mäkelä ; Pitkänen S; Isoherranen K
Acta Derm Venereol; 2023 Aug; 103():adv6579. PubMed ID: 37584092
[TBL] [Abstract][Full Text] [Related]
30. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
[TBL] [Abstract][Full Text] [Related]
31. Daylight photodynamic therapy for field cancerization: lessons from molecular biology.
Rybarski M; Schmitz L; Novak B; Dirschka T
G Ital Dermatol Venereol; 2018 Dec; 153(6):806-810. PubMed ID: 29683291
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
33. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of ablative fractional laser-assisted photodynamic therapy with short-incubation time for the treatment of facial and scalp actinic keratosis: 12-month follow-up results of a randomized, prospective, comparative trial.
Choi SH; Kim KH; Song KH
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1598-605. PubMed ID: 25640401
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
Wiegell SR; Haedersdal M; Eriksen P; Wulf HC
Br J Dermatol; 2009 Jun; 160(6):1308-14. PubMed ID: 19416257
[TBL] [Abstract][Full Text] [Related]
36. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
Fai D; Romano I; Fai C; Cassano N; Vena GA
G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
[TBL] [Abstract][Full Text] [Related]
37. Daylight photodynamic therapy for prevention of new actinic keratosis and keratinocyte carcinomas in organ transplants. A cryotherapy-controlled randomized clinical trial.
Bernad I; Aguado L; Núñez-Córdoba JM; Redondo P
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1464-1470. PubMed ID: 31785169
[TBL] [Abstract][Full Text] [Related]
38. Daylight Photodynamic Therapy for Actinic Keratoses.
Morton CA; Braathen LR
Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
[TBL] [Abstract][Full Text] [Related]
39. A pilot split-face study comparing conventional methyl aminolevulinate-photodynamic therapy (PDT) with microneedling-assisted PDT on actinically damaged skin.
Torezan L; Chaves Y; Niwa A; Sanches JA; Festa-Neto C; Szeimies RM
Dermatol Surg; 2013 Aug; 39(8):1197-201. PubMed ID: 23638986
[TBL] [Abstract][Full Text] [Related]
40. A Randomized Trial of Broad Area ALA-PDT for Field Cancerization Mitigation in High-Risk Patients.
Piacquadio D; Houlihan A; Ferdon MB; Berg JE; Marcus SL
J Drugs Dermatol; 2020 May; 19(5):452-458. PubMed ID: 32484630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
